AKT1 and glioblastoma: miRNAs regulate glycolytic metabolism in GBM by directly targeting the expression of glycolytic genes and/or via the regulation of the expression of oncogenes and tumour suppressors genes in the RTKs pathways and their downstream effector pathways, such as the PI K/Akt pathway, which regulate glycolysis.